Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

ANGO

ANGIODYNAMICS INC

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • ANGOAngiodynamics, Inc.
    10Calm

    A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

    Running, no new patientsPhase 3528 patientsMain results: Apr 2025

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

3 sales (3 not pre-planned) · 0 purchases

  • Trowbridge Stephen AEVP and CFO · Oct 29, 2026Sold 23,615 sharesabout $290 thousand · not pre-planned
  • Trowbridge Stephen AEVP and CFO · Oct 28, 2026Sold 1,720 sharesabout $21 thousand · not pre-planned
  • Nighan Warren JRSVP Quality and Regulatory · Jul 30, 2026Sold 23,370 sharesabout $344 thousand · not pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Oct 8, 2026
  • Shared quarterly results; Shared information with investorsNews report (8-K)Oct 8, 2026
  • Signed a major agreement; An executive or board member joined or leftNews report (8-K)Oct 8, 2026
  • Yearly reportYearly report (10-K)Jul 14, 2026
  • Shared quarterly results; Shared information with investorsNews report (8-K)Jul 14, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.